WASHINGTON (Reuters) – The Senate is unlikely to vote on legislation to pressure China to raise the value of its currency until after the November 2 congressional elections, a Democratic senator said on Tuesday.
Senator Sherrod Brown told reporters he saw strong bipartisan support for currency legislation the House of Representatives is to vote on this week. However, it is unlikely the Senate will vote on the bill before lawmakers recess in coming days to go home to campaign, he said.
House Majority Leader Steny Hoyer told a manufacturing business audience that lawmakers had worked with the Obama administration to ensure that the currency bill the House will pass this week is consistent with World Trade Organization rules.
(Reporting by Doug Palmer; editing by Mohammad Zargham)
EARLY START: The drugstore chain said it has given more than 2 million flu vaccinations since mid-August. Last year it started selling them around Sept. 1.
OUTLOOK: Walgreen gave 7 million flu shots last year and aims to administer 15 million shots this season.
WHAT'S DIFFERENT: Walgreen has hired more pharmacists and expended hours. This year's shots include innoculations for seasonal flu and swine flu, but vaccine shortages hurt sales last year. The government has broadened its recommendations for who should get the shot.
NEW YORK – Walgreen Co., the largest drugstore chain in the U.S., said Tuesday its net income rose 8 percent in the fiscal fourth quarter on higher prescription drug sales.
The results were above analyst expectations, and Walgreen shares jumped more than 10 percent in morning trading.
The company said the flu shot season has been brisk. Since the middle of August it has administered more than 2 million flu shots and sprays. Many of those sales are not included in its fourth-quarter results since the period ended Aug. 31, but Walgreen said is aiming to sell 15 million flu shots this year. That's more than twice as many as the 7 million shots it sold in 2008-09.
The Deerfield, Ill., company reported net income of $470 million, or 49 cents per share, for the quarter. That's up from $436 million, or 44 cents per share, a year earlier. Revenue rose 7 percent to $16.87 billion from $15.7 billion as the company continued to expand.
Analysts on average expected earnings of 44 cents per share and $16.84 billion in revenue, according to Thomson Reuters.
It said the results included 4 cents per share in expenses related to the purchase of Duane Reade, which closed in August and gave the company 258 stores. It reported a penny per share in costs from its restructuring plan. Walgreen expects to save $1 billion per year from that plan.
Walgreen shares rose $3.14, or 10.2 percent, to $33.49 in morning trading.
Sales at stores open at least a year rose 1.5 percent during the quarter, while prescription sales at those stores rose 1.6 percent. Overall, the company said margins for non-pharmacy business benefited from pricing, promotion and other improved efficiencies, while pharmacy margins benefited from new generic introductions.
Walgreen runs 7,561 drugstores around the country. It has opened or acquired 564 locations in the last year, including the Duane Reade chain in New York City.
For the full fiscal year, the company earned $2.09 billion, or $2.12 per share, up from $2.01 billion, or $2.02 per share, in the prior year. Revenue rose to $67.42 billion from $63.34 billion.
The company said it has remodeled and simplified the product lines at more than 1,800 stores in a plan that is designed to boost sales of non-pharmacy items and save money. It plans to renovate about 5,500 and said the changes are costing about $50,000 per store. Walgreen is also selling beer and wine at about 4,200 locations and expects to sell liquor at more than 5,000 stores by the end of this year.